(H4Z3) HSBC MSCI Emerging Markets - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE000KCS7J59 • Global Emerging Markets Equity
H4Z3: Stocks, Bonds, Emerging Markets, Equities, Currencies
HSBC MSCI Emerging Markets UCITS ETF USD Acc EUR (XETRA:H4Z3) is a straightforward ETF designed to track the performance of the MSCI Emerging Markets Index. It provides exposure to a broad range of emerging market equities, covering key regions like Asia, Latin America, Eastern Europe, and the Middle East. The fund is structured as a UCITS-compliant vehicle, domiciled in Ireland, which ensures compliance with European regulatory standards and offers tax efficiencies for European investors.
With an AUM of approximately €2.54 billion, this ETF is sizable enough to maintain liquidity while being nimble enough to efficiently track its underlying index. The fund does not currently report P/E, P/B, or P/S ratios, as these metrics are less relevant for passive, index-tracking ETFs. Its primary goal is to replicate the returns of the MSCI Emerging Markets Index, which is widely regarded as a benchmark for emerging market equities. The index itself is market-cap weighted, ensuring that larger, more established companies in the emerging markets have a greater influence on performance.
Investors should note that this ETF is listed on XETRA, the German exchange, under the ticker H4Z3. It is denominated in euros, which means returns are converted from the underlying USD-denominated index to euros for European investors. The fund’s structure allows it to appeal to both institutional and retail investors looking for cost-effective exposure to emerging markets without the need for direct stock picking or active management.
Key details for investors include the ETF’s tracking error, which measures how closely it follows the MSCI Emerging Markets Index. While historical data is not provided here, tracking error is typically a critical metric for passive funds. Additionally, expense ratios and dividend distributions are important considerations for long-term investors. This ETF’s USD Acc share class indicates that dividends are reinvested, which can be advantageous for compounding returns over time.
For fund managers and institutional investors, this ETF serves as a useful tool for gaining exposure to emerging markets within a diversified portfolio. It can be used for tactical allocations, as a core holding, or as part of a broader asset allocation strategy. The ETF’s liquidity on XETRA ensures that large trades can be executed without significantly impacting the market price, making it suitable for institutional-sized investments.
Ultimately, this ETF is a no-frills, cost-effective way to access emerging market equities. Its alignment with the MSCI Emerging Markets Index ensures
Additional Sources for H4Z3 ETF
H4Z3 ETF Overview
Market Cap in USD | 2,792m |
Category | Global Emerging Markets Equity |
IPO / Inception | 2022-06-28 |
H4Z3 ETF Ratings
Growth 5y | 37.0% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | -12.3 |
Analysts | - |
Fair Price Momentum | 10.08 EUR |
Fair Price DCF | - |
H4Z3 Dividends
No Dividends PaidH4Z3 Growth Ratios
Growth Correlation 3m | 25.1% |
Growth Correlation 12m | 80.5% |
Growth Correlation 5y | 72.8% |
CAGR 5y | 4.09% |
CAGR/Max DD 5y | 0.26 |
Sharpe Ratio 12m | 0.69 |
Alpha | 2.68 |
Beta | 0.64 |
Volatility | 15.71% |
Current Volume | 88.2k |
Average Volume 20d | 64.5k |
As of March 14, 2025, the stock is trading at EUR 10.89 with a total of 88,151 shares traded.
Over the past week, the price has changed by -1.89%, over one month by -4.37%, over three months by -2.24% and over the past year by +9.52%.
Partly, yes. Based on ValueRay Analyses, HSBC MSCI Emerging Markets (XETRA:H4Z3) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 36.97 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of H4Z3 as of March 2025 is 10.08. This means that H4Z3 is currently overvalued and has a potential downside of -7.44%.
HSBC MSCI Emerging Markets has no consensus analysts rating.
According to ValueRays Forecast Model, H4Z3 HSBC MSCI Emerging Markets will be worth about 11.2 in March 2026. The stock is currently trading at 10.89. This means that the stock has a potential upside of +2.57%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 11.2 | 2.6% |